drugset / Trial / NCT00624741

Compassionate Use Study of Pergolide in Patients With Parkinson's Disease

NCT00624741

Expanded access No longer available Bausch Health Americas, Inc.

Summary

This compassionate use study is designed to monitor safety in patients who have been doing well on pergolide therapy, wish to continue treatment, and have not been able to tolerate alternative treatments.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pergolide Small molecule

Indications